GlassScriptPhysician profile
Jerry I Chandy
NPI 1023447695
$11,335.21
in general payments reported to CMS, 2019-2025
52 companies · $1,877 in 2025
The $1,877 reported for 2025 was more than what 93% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,665 · 2022: $2,722 · 2023: $2,062 · 2024: $2,009 · 2025: $1,877.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,948.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,948.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,534.68 | 2021-2025 | Ozempic, Wegovy, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $1,352.95 | 2021-2025 | Airsupra, Breztri, Farxiga |
| Abbvie INC. | $1,318.52 | 2021-2025 | |
| Lilly USA, LLC | $930.54 | 2021-2024 | Jardiance, Mounjaro, Zepbound |
| Glaxosmithkline, LLC. | $824.77 | 2021-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Janssen Pharmaceuticals, INC | $523.55 | 2021-2023 | Xarelto |
| Antares Pharma, INC. | $431.06 | 2022-2025 | Xyosted, Nocdurna, Tlando |
| Pfizer INC. | $429.22 | 2021-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $342.81 | 2021-2025 | Xifaxan |
| Teva Pharmaceuticals USA, INC. | $286.50 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $254.83 | 2021-2024 | |
| Amgen INC. | $251.15 | 2021-2023 | Repatha, Otezla |
| Merck Sharp & Dohme LLC | $214.83 | 2021-2023 | Verquvo |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $212.94 | 2022-2025 | Caplyta |
| Exact Sciences Corporation | $175.00 | 2023-2025 | Cologuard Collection Kit |
Show all 52 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $153.18 | 2021-2023 | |
| Sanofi-Aventis U.S. LLC | $132.69 | 2021-2023 | |
| Sumitomo Pharma America, INC. | $127.25 | 2023-2025 | Gemtesa |
| Axsome Therapeutics, INC. | $121.35 | 2023-2025 | Auvelity |
| Amarin Pharma, INC. | $118.87 | 2021-2022 | |
| Idorsia Pharmaceuticals US INC | $116.24 | 2022-2023 | Quviviq |
| Otsuka America Pharmaceutical, INC. | $111.13 | 2023-2024 | Rexulti |
| Boehringer Ingelheim Pharmaceuticals, INC. | $110.16 | 2024-2025 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $102.68 | 2021-2023 | Eliquis |
| Biohaven Pharmaceutical Holding Company LTD. | $84.82 | 2022 | |
| Abbott Laboratories | $82.94 | 2021-2023 | Freestyle Libre 3 |
| Biohaven Pharmaceuticals, INC. | $82.50 | 2021 | |
| Verity Pharmaceuticals INC. | $76.34 | 2025 | Tlando, Trelstar |
| Mylan Specialty L.P. | $65.95 | 2021-2024 | Yupelri |
| Phathom Pharmaceuticals, INC. | $60.11 | 2024 | Voquezna |
| Horizon Therapeutics Plc | $55.10 | 2021-2022 | |
| Viatris Specialty LLC | $54.97 | 2025 | Yupelri |
| Urovant Sciences INC | $51.39 | 2022 | |
| Phadia US INC. | $50.20 | 2023-2024 | Immunocap |
| Xeris Pharmaceuticals, INC. | $44.56 | 2025 | Gvoke Hypopen |
| Biogen, INC. | $43.25 | 2024-2025 | Skyclarys |
| Takeda Pharmaceuticals U.S.A., INC. | $40.87 | 2022 | |
| Halozyme INC | $39.28 | 2023 | |
| Tolmar, INC. | $31.44 | 2024-2025 | Jatenzo |
| Shield Therapeutics INC | $29.87 | 2022-2025 | |
| Dexcom, INC. | $29.09 | 2021 | |
| Ardelyx, INC. | $28.13 | 2024-2025 | Ibsrela |
| Sage Therapeutics, LLC | $27.13 | 2024 | |
| Medtronic, INC. | $26.66 | 2025 | Venaseal |
| Astellas Pharma US INC | $24.95 | 2025 | Veozah |
| Cmp Pharma, INC. | $22.98 | 2022 | |
| Lundbeck LLC | $19.61 | 2023 | Rexulti |
| Corcept Therapeutics | $18.74 | 2025 | Korlym |
| Alkermes, INC. | $18.46 | 2025 | Aristada, Lybalvi |
| Seqirus USA INC | $18.10 | 2025 | Flucelvax, Fluad |
| Bausch Health US, LLC | $15.45 | 2021 | |
| Boston Scientific Corporation | $15.42 | 2023 | Watchman Flx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jerry Chandy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.